How Temi’s telehealth blog tripled its Google clicks
From 43 clicks in six months to 847 in three, and 8,570 appearances in Google’s AI answers. Every number below is pulled directly from Temi’s Google Search Console.

3×
Google clicks per day (4.2 in July → 12.6 in October)
4.5×
Google impressions per day (519 → 2,332)
11×
Impressions in Google’s AI answers (15 → 170 a day)
69
Articles averaging a first-page position
THE CHALLENGE
A health blog Google wasn’t showing.
Temi is a US cash-pay telehealth service for GLP-1 weight-loss care and prescription refills. From January to mid-July 2026, its blog got 43 clicks from Google, about one every four or five days.
Health is one of the hardest topics to rank for. Google treats medical content as “Your Money or Your Life” and favours Drugs.com, Mayo Clinic and the big telehealth brands. Meanwhile, Temi’s patients were asking specific questions (can I split my dose, why hasn’t my refill arrived, what if my package arrived warm) that few sites answered well.
HOW IT HAPPENED
Patient questions, answered first, published every week.
Here’s the week-by-week view of what we did and how Google responded.

Before July: 0.2 clicks a day.
- Patient questions, not head terms. SEO Sorted tracked 233 keywords and flagged 112 quick wins: specific questions like “can I split my tirzepatide dose”. Broad terms like “Ozempic” were left to Drugs.com.
- Five topic groups. Tirzepatide and Zepbound; semaglutide, Ozempic and Wegovy; refill and pharmacy problems; new drugs in trials; everyday medicines.
- Answer first. Every article gives a short answer near the top. That’s what Google lifts into AI Overviews.
- Show the evidence. Prescribing information, named trials, a numbered reference list, and a physician byline.
- Published automatically. SEO Sorted published 91 articles from September 6 to October 15, about 15 a week, straight to Temi’s site.
KEYWORD WINS
Owning the questions patients actually ask.
| Target keyword | Before | After |
|---|---|---|
| “tirzepatide half dose twice a week” | Pos 5.5 | Pos 2.9 |
| “can i split my zepbound dose to twice a week” | Pos 6.8 | Pos 3.4 |
| “how much can glp-1 prices vary between pharmacies” | Not ranked | Pos 4.2 |
| “orforglipron brand name” | Not ranked | Pos 8.3 |
Average Google position, first 4 weeks (Jul 13–Aug 9) vs last 4 weeks (Sep 18–Oct 15).
IMPACT WE CREATED
From invisible to cited by Google’s AI.
In three months the blog earned 847 clicks and 152,000 impressions. It now ranks for 1,000+ searches, with 493 averaging the first page and 61 in the top three. The biggest shift was in AI answers: 92 articles now appear in AI Overviews and AI Mode, 8,570 times in total.


Impressions in Google’s AI features grew about 11× (Search Console, Generative AI features report, beta).
BREAKOUT ARTICLE
“Can I split my tirzepatide dose?” earned 664 clicks and 51,254 impressions at an average position of 6.6, plus 5,553 AI impressions. Google even links straight to its sections, like “The short answer”.
WHAT’S NEXT
Scaling the playbook across every drug and every question.
60 more articles are written and ready to publish. Next come new page types built for how patients compare options, such as drug vs drug and provider vs provider, so Temi shows up at every step from “what is this drug” to “where do I get it”.
HONEST READING
What this data does not show.
- One article, on splitting a tirzepatide dose, drove 664 of the 847 clicks.
- The 91 newest articles have only had 1–6 weeks in Google; 76 already appear in search.
- Clicks are not patients. This page doesn’t cover sign-ups or prescriptions.
- Source: Google Search Console, usetemi.com, /blog/ pages, Jul 13–Oct 15, 2026; “before” = Jan 1–Jul 12, 2026.
Running a health or telehealth startup?
Get a free SEO + AI visibility report and see which patient questions you could own.
Common questions

Clicks rose in the first month and stepped up again about eight weeks in. AI impressions grew fastest after September.
Yes, when it’s accurate, cites its sources and has a qualified reviewer. Temi’s articles carry a physician byline, trial references and a numbered source list.
Each time a page is shown as a source in Google’s AI Overviews or AI Mode. Search Console reports it in the Generative AI features report.
The method does: answer specific customer questions, answer first, cite sources, publish steadily. Results depend on your niche and competition.
No. SEO Sorted researched keywords, wrote in Temi’s voice and published to Temi’s site automatically.


